Download PDF
Semin Respir Crit Care Med 2013; 34(03): 361-370
DOI: 10.1055/s-0033-1348464
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Donor Selection and Management

Gregory I. Snell
1   Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia
,
Miranda Paraskeva
1   Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia
,
Glen P. Westall
1   Lung Transplant Service, Alfred Hospital and Monash University, Melbourne, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2013 (online)

    Permissions and Reprints

Abstract

This article reviews recent developments in the selection, assessment, and management of the potential lung donor, which aim to increase donor organ use. The scarcity of suitable donor organs continues to limit lung transplantation, but the situation is changing. An expanded donor pool, including the now widespread use of donation after cardiac death (DCD) lungs; the use of extended donor lungs; and the ability of ex vivo lung perfusion (EVLP) to evaluate and improve donor lungs are key initiatives. These strategies have substantially lifted donor lung utilization rates from historically low levels of less than 15% to rates greater than 50%. Indeed, since 2004 there has been an accelerated year-on-year increase in the number of lungs transplanted globally. Intermediate-term studies are now confirming that long-term outcomes are not being significantly compromised and that more individuals with terminal, symptomatic lung disease are being transplanted. It is now quite clear that many of the historical factors used to define a lung as “extended” do not actually produce significantly inferior outcomes. There has been a dramatic increase in research and clinical interest in donor lung assessment, management, and novel therapeutic strategies. The lessons learned are now being applied widely beyond the lung as researchers aim to increase availability and optimize other solid organs for transplantation.

Keywords

lung transplantation - donation after cardiac death - ex vivo lung perfusion - organ donor - donor management
 

  • References

  • 1 Christie JD, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report—2012. J Heart Lung Transplant 2012; 31 (10) 1073-1086
    CrossrefPubMedGoogle Scholar
  • 2 Levvey BJ, Harkess M, Hopkins P , et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant 2012; 12 (9) 2406-2413
    CrossrefPubMedGoogle Scholar
  • 3 Stehlik J, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report—2012. J Heart Lung Transplant 2012; 31 (10) 1052-1064
    CrossrefPubMedGoogle Scholar
  • 4 Mason DP, Brown CR, Murthy SC , et al. Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg 2012; 94 (2) 406-411 , discussion 411–412
    CrossrefPubMedGoogle Scholar
  • 5 Botha P, Trivedi D, Weir CJ , et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006; 131 (5) 1154-1160
    CrossrefPubMedGoogle Scholar
  • 6 Snell GI, Griffiths A, Levvey BJ, Oto T. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant 2008; 27 (6) 662-667
    CrossrefPubMedGoogle Scholar
  • 7 Snell GI, Westall GP. Selection and management of the lung donor. Clin Chest Med 2011; 32 (2) 223-232
    CrossrefPubMedGoogle Scholar
  • 8 Cypel M, Yeung JC, Liu M , et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364 (15) 1431-1440
    CrossrefPubMedGoogle Scholar
  • 9 Ingemansson R, Eyjolfsson A, Mared L , et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87 (1) 255-260
    CrossrefPubMedGoogle Scholar
  • 10 Detry O, Le Dinh H, Noterdaeme T , et al. Categories of donation after cardiocirculatory death. Transplant Proc 2012; 44 (5) 1189-1195
    CrossrefPubMedGoogle Scholar
  • 11 Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27 (5) 2893-2894
    PubMedGoogle Scholar
  • 12 Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant 2004; 23 (1) 3-10
    CrossrefPubMedGoogle Scholar
  • 13 Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357 (9259) 825-829
    CrossrefPubMedGoogle Scholar
  • 14 Gomez-de-Antonio D, Campo-Cañaveral JL, Crowley S , et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. J Heart Lung Transplant 2012; 31 (4) 349-353
    CrossrefPubMedGoogle Scholar
  • 15 Mason DP, Rajeswaran J, Li L , et al. Effect of changes in postoperative spirometry on survival after lung transplantation. J Thorac Cardiovasc Surg 2012; 144 (1) 197-203
    CrossrefPubMedGoogle Scholar
  • 16 Van De Wauwer C, Verschuuren EA, van der Bij W, Nossent GD, Erasmus ME. The use of non-heart-beating lung donors category III can increase the donor pool. Eur J Cardiothorac Surg 2011; 39 (6) e175-e180 , discussion e180
    CrossrefPubMedGoogle Scholar
  • 17 Zych B, Popov AF, Amrani M , et al. Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution. Eur J Cardiothorac Surg 2012; 42 (3) 542-549
    CrossrefPubMedGoogle Scholar
  • 18 Levvey B. Excellent early results of Australian DCD lung transplantation. J Heart Lung Transplant 2010; 31 (2) S63-S64
    PubMedGoogle Scholar
  • 19 Kang CH, Anraku M, Cypel M , et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2011; 30 (3) 289-298
    CrossrefPubMedGoogle Scholar
  • 20 Stamenkovic S, Van Raemdonck D, Verleden G , et al. Bilateral lobar lung transplantation—the first two cases in Belgium. Acta Chir Belg 2007; 107 (2) 201-204
    PubMedGoogle Scholar
  • 21 Keating DT, Westall GP, Marasco SF , et al. Paediatric lobar lung transplantation: addressing the paucity of donor organs. Med J Aust 2008; 189 (3) 173-175
    PubMedGoogle Scholar
  • 22 Sweet SC, Wong HH, Webber SA , et al. Pediatric transplantation in the United States, 1995-2004. Am J Transplant 2006; 6 (5, Pt 2) 1132-1152
    CrossrefPubMedGoogle Scholar
  • 23 Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5 (1) 145-148
    CrossrefPubMedGoogle Scholar
  • 24 Nelson PW, Bryan CF. When will real benefits for minority patients be realized with A2—>B transplants?. Transplantation 2010; 89 (11) 1310-1311
    CrossrefPubMedGoogle Scholar
  • 25 Banner NR, Rose ML, Cummins D , et al. Management of an ABO-incompatible lung transplant. Am J Transplant 2004; 4 (7) 1192-1196
    CrossrefPubMedGoogle Scholar
  • 26 Pierson III RN, Loyd JE, Goodwin A , et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002; 74 (1) 79-84
    CrossrefPubMedGoogle Scholar
  • 27 Strüber M, Warnecke G, Hafer C , et al. Intentional ABO-incompatible lung transplantation. Am J Transplant 2008; 8 (11) 2476-2478
    CrossrefPubMedGoogle Scholar
  • 28 Grasemann H, de Perrot M, Bendiak GN , et al. ABO-incompatible lung transplantation in an infant. Am J Transplant 2012; 12 (3) 779-781
    CrossrefPubMedGoogle Scholar
  • 29 Strüber M, Warnecke G, Hafer C , et al. Intentional ABO-incompatible lung transplantation. Am J Transplant 2008; 8 (11) 2476-2478
    CrossrefPubMedGoogle Scholar
  • 30 Patel M, Carby M, Rice A, Cummins D, Banner NR. Medium-term outcome of an ABO incompatible lung transplant. Am J Transplant 2010; 10 (3) 702-703
    CrossrefPubMedGoogle Scholar
  • 31 Barnett AN, Hudson A, Hadjianastassiou VG , et al. Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy. Transplantation 2012; 94 (4) 362-368
    PubMedGoogle Scholar
  • 32 Kobayashi T, Liu D, Ogawa H , et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol 2009; 20 (3) 132-138
    CrossrefPubMedGoogle Scholar
  • 33 Yamane M, Sano Y, Toyooka S, Okazaki M, Date H, Oto T. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Transplantation 2008; 86 (12) 1767-1770
    CrossrefPubMedGoogle Scholar
  • 34 Bando T, Date H, Minami M , et al. First registry report: lung transplantation in Japan: The Japanese Society of Lung and Heart-Lung Transplantation. Gen Thorac Cardiovasc Surg 2008; 56 (1) 17-21
    CrossrefPubMedGoogle Scholar
  • 35 Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56 (6) 1409-1413
    CrossrefPubMedGoogle Scholar
  • 36 Orens JB, Boehler A, de Perrot M , et al; Pulmonary Council, International Society for Heart and Lung Transplantation. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003; 22 (11) 1183-1200
    CrossrefPubMedGoogle Scholar
  • 37 Botha P, Rostron AJ, Fisher AJ, Dark JH. Current strategies in donor selection and management. Semin Thorac Cardiovasc Surg 2008; 20 (2) 143-151
    CrossrefPubMedGoogle Scholar
  • 38 Van Raemdonck D, Neyrinck A, Verleden GM , et al. Lung donor selection and management. Proc Am Thorac Soc 2009; 6 (1) 28-38
    CrossrefPubMedGoogle Scholar
  • 39 Snell GI, Westall GP. Donor selection and management. Curr Opin Organ Transplant 2009; 14 (5) 471-476
    CrossrefPubMedGoogle Scholar
  • 40 Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002; 123 (3) 421-427 , discussion, 427–428
    CrossrefPubMedGoogle Scholar
  • 41 Schiavon M, Falcoz PE, Santelmo N, Massard G. Does the use of extended criteria donors influence early and long-term results of lung transplantation?. Interact Cardiovasc Thorac Surg 2012; 14 (2) 183-187
    CrossrefPubMedGoogle Scholar
  • 42 Meers C, Van Raemdonck D, Verleden GM , et al. The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int 2010; 23 (6) 628-635
    CrossrefPubMedGoogle Scholar
  • 43 Levvey B. The Lung Allocation Score in a non-US lung transplant program. J Heart Lung Transplant 2009; 29 (2) S135
    PubMedGoogle Scholar
  • 44 Gabbay E, Williams TJ, Griffiths AP , et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160 (1) 265-271
    CrossrefPubMedGoogle Scholar
  • 45 Snell GI, Griffiths A, Macfarlane L , et al. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant 2000; 19 (4) 401-407
    CrossrefPubMedGoogle Scholar
  • 46 Oto T, Levvey BJ, Whitford H , et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 2007; 83 (1) 257-263
    CrossrefPubMedGoogle Scholar
  • 47 Iribarne A, Russo MJ, Davies RR , et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest 2009; 135 (4) 923-928
    CrossrefPubMedGoogle Scholar
  • 48 Porro GA, Valenza F, Coppola S , et al. Use of the Oto lung donor score to analyze the 2010 donor pool of the Nord Italia Transplant program. Transplant Proc 2012; 44 (7) 1830-1834
    CrossrefPubMedGoogle Scholar
  • 49 Reyes KG, Mason DP, Thuita L , et al. Guidelines for donor lung selection: time for revision?. Ann Thorac Surg 2010; 89 (6) 1756-1764 , discussion 1764–1765
    CrossrefPubMedGoogle Scholar
  • 50 Organ Procurement and Transplant Network; 2006 Annual Report. http://www.optn.org/AR2006
    PubMed
  • 51 Zafar F, Khan MS, Heinle JS , et al. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants. J Thorac Cardiovasc Surg 2012; 143 (4) 919-925
    CrossrefPubMedGoogle Scholar
  • 52 Government of Australia. Deaths in Australia. Canberra, Australia: Australian Bureau of Statistics; 2008: 73
    Google Scholar
  • 53 Opdam HI, Silvester W. Potential for organ donation in Victoria: an audit of hospital deaths. Med J Aust 2006; 185 (5) 250-254
    PubMedGoogle Scholar
  • 54 Ojo AO, Wolfe RA, Leichtman AB, Dickinson DM, Port FK, Young EW. A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation 1999; 67 (4) 548-556
    CrossrefPubMedGoogle Scholar
  • 55 Meyers BF, Patterson GA. Current status of lung transplantation. Adv Surg 2000; 34: 301-318
    PubMedGoogle Scholar
  • 56 De Perrot M, Waddell TK, Shargall Y , et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007; 133 (2) 525-531
    CrossrefPubMedGoogle Scholar
  • 57 Penn I, Halgrimson CG, Starzl TE. De novo malignant tumors in organ transplant recipients. Transplant Proc 1971; 3 (1) 773-778
    PubMedGoogle Scholar
  • 58 Chen F, Karolak W, Cypel M, Keshavjee S, Pierre A. Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme. J Heart Lung Transplant 2009; 28 (10) 1116-1118
    CrossrefPubMedGoogle Scholar
  • 59 Armanios MY, Grossman SA, Yang SC , et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro-oncol 2004; 6 (3) 259-263
    PubMedGoogle Scholar
  • 60 Chen H, Shah AS, Girgis RE, Grossman SA. Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol 2008; 26 (19) 3284-3285
    CrossrefPubMedGoogle Scholar
  • 61 Penn I. Donor transmitted disease: cancer. Transplant Proc 1991; 23 (5) 2629-2631
    PubMedGoogle Scholar
  • 62 Bajaj NS, Watt C, Hadjiliadis D , et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int 2010; 23 (7) e26-e31
    CrossrefPubMedGoogle Scholar
  • 63 Gandhi MJ, Strong DM. Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007; 8 (4) 267-286
    CrossrefPubMedGoogle Scholar
  • 64 Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007; 84 (2) 272-274
    CrossrefPubMedGoogle Scholar
  • 65 Bonde PN, Patel ND, Borja MC , et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006; 25 (1) 99-105
    CrossrefPubMedGoogle Scholar
  • 66 Avlonitis VS, Krause A, Luzzi L , et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003; 24 (4) 601-607
    CrossrefPubMedGoogle Scholar
  • 67 Mattner F, Kola A, Fischer S , et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection 2008; 36 (3) 207-212
    CrossrefPubMedGoogle Scholar
  • 68 Len O, Gavaldà J, Blanes M , et al; Spanish Research Network for the Study of Infection in Transplantation. Donor infection and transmission to the recipient of a solid allograft. Am J Transplant 2008; 8 (11) 2420-2425
    CrossrefPubMedGoogle Scholar
  • 69 Palacios G, Druce J, Du L , et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358 (10) 991-998
    CrossrefPubMedGoogle Scholar
  • 70 Iwamoto M, Jernigan DB, Guasch A , et al; West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348 (22) 2196-2203
    CrossrefPubMedGoogle Scholar
  • 71 Srinivasan A, Burton EC, Kuehnert MJ , et al; Rabies in Transplant Recipients Investigation Team. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352 (11) 1103-1111
    CrossrefPubMedGoogle Scholar
  • 72 Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008; 358 (26) 2832-2837
    CrossrefPubMedGoogle Scholar
  • 73 Fong TL, Cho YW, Hou L, Hutchinson IV, Barbers RG, Herrington CS. Outcomes after lung transplantation and practices of lung transplant programs in the United States regarding hepatitis C seropositive recipients. Transplantation 2011; 91 (11) 1293-1296
    CrossrefPubMedGoogle Scholar
  • 74 Davern TJ, Chalasani N, Fontana RJ , et al; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141 (5) 1665-1672 , e1–e9
    CrossrefPubMedGoogle Scholar
  • 75 Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J. Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet 2012; 380 (9843) 747-755
    CrossrefPubMedGoogle Scholar
  • 76 Macrae F. Cystic fibrosis sufferer given smoker's lungs in transplant dies of cancer. Available at: www.dailymail.co.uk/health/article-2249189
    PubMedGoogle Scholar
  • 77 Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant 2008; 27 (1) 78-85
    CrossrefPubMedGoogle Scholar
  • 78 Ferraro P, Martin J, Dery J , et al. Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction. Ann Thorac Surg 2008; 86 (4) 1123-1129
    CrossrefPubMedGoogle Scholar
  • 79 Sapru A, Zaroff JG, Pawlikowska L , et al; DOGMATIC Study Investigators. The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization. Am J Transplant 2012; 12 (7) 1848-1854
    CrossrefPubMedGoogle Scholar
  • 80 Kaneda H, Waddell TK, de Perrot M , et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6 (3) 544-551
    CrossrefPubMedGoogle Scholar
  • 81 Anraku M, Cameron MJ, Waddell TK , et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 2008; 8 (10) 2140-2148
    CrossrefPubMedGoogle Scholar
  • 82 Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7 (10) 2396-2405
    CrossrefPubMedGoogle Scholar
  • 83 Oto T, Excell L, Griffiths AP , et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant 2008; 8 (10) 2132-2139
    CrossrefPubMedGoogle Scholar
  • 84 Cooper DK. Hormonal resuscitation therapy in the management of the brain-dead potential organ donor. Int J Surg 2008; 6 (1) 3-4
    CrossrefPubMedGoogle Scholar
  • 85 Shah VR. Aggressive management of multiorgan donor. Transplant Proc 2008; 40 (4) 1087-1090
    CrossrefPubMedGoogle Scholar
  • 86 Venkateswaran RV, Patchell VB, Wilson IC , et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85 (1) 278-286 , discussion 286
    CrossrefPubMedGoogle Scholar
  • 87 Rosendale JD, Kauffman HM, McBride MA , et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75 (4) 482-487
    CrossrefPubMedGoogle Scholar
  • 88 Steen S, Sjöberg T, Liao Q, Bozovic G, Wohlfart B. Pharmacological normalization of circulation after acute brain death. Acta Anaesthesiol Scand 2012; 56 (8) 1006-1012
    CrossrefPubMedGoogle Scholar
  • 89 Rostron AJ, Avlonitis VS, Cork DM, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation 2008; 85 (4) 597-606
    CrossrefPubMedGoogle Scholar
  • 90 Minambres E, Ballesteros MA, Rodrigo E , et al. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation. Clin Transplant 2013; 27 (1) 52-59
    CrossrefPubMedGoogle Scholar
  • 91 Christmas AB, Bogart TA, Etson KE , et al. The reward is worth the wait: a prospective analysis of 100 consecutive organ donors. Am Surg 2012; 78 (3) 296-299
    PubMedGoogle Scholar
  • 92 Mascia L, Pasero D, Slutsky AS , et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304 (23) 2620-2627
    CrossrefPubMedGoogle Scholar
  • 93 Marasco SF, Bailey M, McGlade D , et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant 2011; 30 (4) 414-419
    CrossrefPubMedGoogle Scholar
  • 94 Cypel M, Yeung JC, Hirayama S , et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27 (12) 1319-1325
    CrossrefPubMedGoogle Scholar
  • 95 Aigner C, Slama A, Hötzenecker K , et al. Clinical ex vivo lung perfusion—pushing the limits. Am J Transplant 2012; 12 (7) 1839-1847
    CrossrefPubMedGoogle Scholar
  • 96 Zych B, Popov AF, Stavri G , et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31 (3) 274-281
    CrossrefPubMedGoogle Scholar
  • 97 Cypel M, Yeung JC, Machuca T , et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012; 144 (5) 1200-1206
    CrossrefPubMedGoogle Scholar
  • 98 Dong BM, Abano JB, Egan TM. Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function. Am J Transplant 2009; 9 (12) 2707-2715
    CrossrefPubMedGoogle Scholar
  • 99 Inci I, Ampollini L, Arni S , et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008; 27 (11) 1229-1236
    CrossrefPubMedGoogle Scholar
  • 100 Inci I, Zhai W, Arni S , et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007; 26 (10) 1054-1060
    CrossrefPubMedGoogle Scholar
  • 101 Hirayama S, Cypel M, Sato M , et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J Heart Lung Transplant 2009; 28 (11) 1180-1184
    CrossrefPubMedGoogle Scholar
  • 102 Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005; 130 (1) 194-201
    CrossrefPubMedGoogle Scholar
  • 103 Yeung JC, Wagnetz D, Cypel M , et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012; 20 (6) 1204-1211
    CrossrefPubMedGoogle Scholar
  • 104 Cypel M, Rubacha M, Yeung J , et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9 (10) 2262-2269
    CrossrefPubMedGoogle Scholar